Ostara Biomedical Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.24M
Latest Deal Amount
  • Investors
  • 6

Ostara Biomedical General Information

Description

Operator of a medical research agency intended to target artificial animal breeding and related experiments. The company's agency targets significant opportunities in the improvement of success rates in artificial reproduction across a range of mammalian species, enabling clients to avail increased efficiencies and reduction in costs by streamlining animal breeding systems to increase animal welfare and reduce the overall numbers of animals used.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Animal Husbandry
Biotechnology
Primary Office
  • Liverpool Science Park
  • 131 Mount Pleasant
  • Liverpool L3 5TF
  • England, United Kingdom

Ostara Biomedical Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ostara Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 17-Oct-2019 $1.24M 00.00 Completed Generating Revenue
7. Secondary Transaction - Private 01-Jan-2019 00.00 Completed Generating Revenue
6. Later Stage VC 02-Nov-2018 00000 00.00 00.000 Completed Generating Revenue
5. Early Stage VC 07-Mar-2016 00.000 00.000 00.000 Completed Generating Revenue
4. Grant 09-Feb-2015 00000 00000 Completed Generating Revenue
3. Early Stage VC 09-Sep-2014 00000 00000 00.000 Completed Generating Revenue
2. Grant 01-Dec-2013 $403K $253K Completed Startup
1. Early Stage VC 29-Apr-2013 $253K $253K 00.000 Completed Startup
To view Ostara Biomedical’s complete valuation and funding history, request access »

Ostara Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
A Ordinary 4,300 $0.013019 $65.1 $65.1 1x $65.1 6.69%
Ordinary 8,000 $0.013019 $65.1 $65.1 1x $65.1 12.44%
To view Ostara Biomedical’s complete cap table history, request access »

Ostara Biomedical Executive Team (4)

Name Title Board Seat Contact Info
Nadia Gopichandran Ph.D Co-Founder & Chief Executive Officer
Richard Smith Chief Financial Officer
Sarah Field Ph.D Technical Director
You’re viewing 3 of 4 executive team members. Get the full list »

Ostara Biomedical Board Members (6)

Name Representing Role Since
John McKinley Ostara Biomedical Chairman of the Board 000 0000
Nadia Orsi Ostara Biomedical Board Member 000 0000
Paul Hedgeland Ostara Biomedical Board Member 000 0000
You’re viewing 3 of 6 board members. Get the full list »

Ostara Biomedical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ostara Biomedical Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NWF4B Venture Capital Minority 000 0000 000000 0
Praetura Ventures Venture Capital Minority 000 0000 000000 0
Biotechnology and Biological Science Research Council Limited Partner 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
NC3Rs Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »